The community gives you the chance to connect and engage with delegates attending this event.

Access to the community is available for registered attendees only.

If you have already registered, please join using the link below. To register for the event please follow the 'Register for free' button and summit your details. Please contact ftlive@ft.com with any questions.

Alzheimer's Disease: Preparing for the “Silent Epidemic” in Europe

On-demand video now available

View on-demand now

Presented by

In Partnership with

According to the World Health Organization, the number of people aged 60 years and older is set to increase from 1 billion in 2019 to 2.1 billion by 2050. This is a key driver behind the growing prevalence of Alzheimer’s disease and its increasingly heavy burden on health systems.

New care options for Alzheimer’s disease under development hold great potential. However, public awareness is severely lacking, as is the capacity of many health systems for early detection and diagnosis. As prevalence continues to rise and the treatment landscape evolves, healthcare stakeholders will need to engage with patients sooner and with greater urgency to drive better outcomes.

This webinar, hosted by the Financial Times in partnership with Biogen and eu40, will consider fundamental changes needed to increase awareness of Alzheimer’s disease, improve diagnosis rates and enhance options for care.

Speakers

Francesca Colombo

Head of Health Division

Organisation for Economic Co-operation and Development

Dominik Isler

Partner

Dementia Meets

Miia Kivipelto

Professor of Clinical Geriatrics, Center for Alzheimer Research

Karolinska Institutet

Alessandro Marcuzzi

Vice President, Head of Alzheimer’s Disease, Europe, Canada & European Partner Markets

Biogen

Donata Meroni

Head of Unit – Health Promotion, Disease Prevention and Financial Instruments

European Commission

Sarah Neville

Global Health Editor

Financial Times

Key themes

Health System Readiness

What are the key challenges in healthcare readiness for Alzheimer’s disease and how do they vary across Europe? What can be done to improve health infrastructure?

Public Awareness

How can public awareness of Alzheimer’s disease be increased in a way that reduces stigma and leads to earlier intervention?

Leadership

Where is the political leadership on Alzheimer’s disease? How can governments work with other stakeholders to drive progress?

See the agenda

Why Attend?

Understand

The big picture, not just the individual strands of the business you work in

Connect

And build relationships with some of the biggest names in your industry

Discover

New approaches and strategies to help win market share

Register to watch on-demand now

Our webinars provide unique opportunities to engage global senior audiences. All access, digital passes include access to all the live sessions PLUS all sessions on demand for 30 days. Join the conversation.

View on-demand now